Sawgrass Asset Management’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$276K Buy
2,887
+61
+2% +$5.56K 0.04% 158
2026
Q1
$272K Buy
2,826
+112
+4% +$11.2K 0.04% 156
2025
Q4
$264K Buy
+2,714
New +$233K 0.03% 159
2022
Q2
Sell
-6,102
Closed -$274K 159
2022
Q1
$274K Buy
+6,102
New +$282K 0.03% 147

Other funds holding IRMD

Sawgrass Asset Management's IRMD Position: Q2 2026 in Review

Sawgrass Asset Management increased its iRadimed (IRMD) stake by 2.2% in Q2 2026, buying an estimated $5.56K and bringing the position to 2,887 shares worth $276K. The position accounts for 0.04% of the portfolio, ranked #158.

Sawgrass Asset Management first reported a position in IRMD in Q1 2022 and has held it in 4 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Sawgrass Asset Management held 2,887 shares of iRadimed worth $276K as of Q2 2026.
  • Sawgrass Asset Management bought 61 iRadimed shares in Q2 2026, an estimated $5.56K.
  • iRadimed made up 0.04% of Sawgrass Asset Management's portfolio in Q2 2026, its #158 holding.
  • Sawgrass Asset Management first reported a position in iRadimed in Q1 2022 and has held it in 4 quarters since.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Sawgrass Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.